A Multi¿Center, Open¿Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
Clinical Trial Grant
Awarded By
TG Therapeutics, Inc
Start Date
September 1, 2016
End Date
August 31, 2022
Awarded By
TG Therapeutics, Inc
Start Date
September 1, 2016
End Date
August 31, 2022